New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 2, 2014
10:24 EDTOREX, MJNOptions with increasing implied volatility: OREX MJN SWY
News For OREX;MJN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 23, 2015
11:54 EDTOREXOptions with increasing call volume
Subscribe for More Information
07:55 EDTMJNMead Johnson management to meet with JPMorgan
Subscribe for More Information
07:39 EDTMJNMead Johnson sees FY15 EPS $3.63-$3.78, consensus $3.69
Subscribe for More Information
07:38 EDTMJNMead Johnson reports Q2 adjusted EPS 76c, consensus 77c
Reports Q2 revenue $1.03B, consensus $1.05B.
July 15, 2015
12:18 EDTMJNOn The Fly: Top stock stories at midday
Subscribe for More Information
11:44 EDTMJNMead Johnson volatility low, shares at one-year low after reducing 2015 guidance
Mead Johnson August call option implied volatility is at 26, November is at 23; compared to its 52-week range of 19 to 48; suggesting decreasing price movement after reducing fiscal 2015 EPS guidance.
11:08 EDTMJNFormula makers slip after Mead Johnson cuts guidance
Subscribe for More Information
10:09 EDTMJNMead Johnson falls, levels to watch
Subscribe for More Information
09:23 EDTMJNOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Bank of America (BAC), up 2.9%... CSX (CSX), up 2.6%. ALSO HIGHER: Hertz (HTZ), up 3.9% after being upgraded to Buy from Hold at Deutsche Bank. NOTABLE: Receptos (RCPT), up 10.5% following deal to be acquired by Celgene (CELG)... Celgene is up 7.9% after announcing acquisition of Receptos... UP AFTER RECEPTOS/CELGENE DEAL: ZIOPHARM Oncology (ZIOP), up 1.7%... Arena Pharmaceuticals (ARNA), up 6.5%. DOWN AFTER EARNINGS: Delta Air Lines (DAL), down 2.4%. ALSO LOWER: Mead Johnson (MJN), down 4.8% after reducing fiscal 2015 EPS guidance... Columbia Pipeline Partners (CPPL), down 5.6% after 4.64M share Block Trade priced at $24.15... SINA (SINA), down 2.7% after being downgraded to Hold from Buy at Deutsche Bank... MacroGenics (MGNX), down 2.8% after 3.25M share Secondary priced at $37.00.
07:39 EDTMJNMead Johnson price target lowered to $89 from $99 at JPMorgan
Subscribe for More Information
July 14, 2015
19:05 EDTMJNOn The Fly: Pre-market Movers
UP AFTER EARNINGS: CSX (CSX), up 3.5%. ALSO HIGHER: Receptos (RCPT), up 10.2% following deal to be acquired by Celgene (CELG)... Celgene is up 5.8% after announcing acquisition of Receptos... Celsion (CLSN), up 8.8% after being initiated with a Buy at BTIG... Aratana Therapeutics (PETX), up 10% after results of pivotal study of AT-003. DOWN AFTER EARNINGS: Peregrine (PPHM), down 3%... Yum! Brands (YUM), down marginally. ALSO LOWER: Allegheny Technologies (ATI), down 9.3% after providing second quarter EPS guidance... Mead Johnson (MJN), down 4.8% after reducing fiscal 2015 EPS guidance.
17:29 EDTMJNMead Johnson cuts FY15 adjusted EPS to $3.63-$3.78 from $3.90-$4.00
Mead Johnson announced that it is revising FY15 financial guidance based on preliminary Q2 sales results. Annual sales growth is expected to be in the range of 0%-2% on a constant-dollar basis, previously estimated at 7%. Including the estimated impact of foreign exchange, reported sales are expected to be 2% to 4% below the prior year, previously estimated to be 2% above the prior year. FY15 non-GAAP EPS is expected to be in the range of $3.63-$3.78, previously estimated at $3.90-$4.00. EPS consensus is $3.93. Specified items are currently expected to be 7c per share, excluding any future mark-to-market pension adjustment. As a result, full-year GAAP EPS guidance is expected to be in the range of $3.56-$3.71, previously estimated at $3.79-$3.89.
17:27 EDTMJNMead Johnson sees Q2 adjusted EPS 76c, consensus 89c
Mead Johnson Nutrition announced that preliminary Q2 constant dollar sales were 3% below the prior year quarter. Including the impact of foreign currency, preliminary reported sales were 7% below the prior year quarter. "Strong sales of the recently launched imported products to China were insufficient to fully offset declines in the China based manufactured products. Hong Kong cross-border sales stabilized, but were below prior year levels... Slowing emerging market growth and dairy costs approaching five-year lows drove competitive promotional price discounting across several markets in Latin America and Asia," said the company. Preliminary year-to-date sales were in-line with the prior year on a constant-dollar basis and 4% lower on a reported basis. Preliminary non-GAAP and GAAP EPS for Q2 are expected to be 76c and 80c, respectively. EPS consensus is 89c.
17:22 EDTMJNMead Johnson cuts FY15 guidance based on preliminary Q2 results

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use